Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial

Baraliakos X, Gossec L, Pournara E, Jeka S, Blanco R, D'Angelo S, Schett G, Schulz B, Rissler M, Whyms D, Perella C, Coates L (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

DOI: 10.1093/rheumatology/keab247.179

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Ospedale San Carlo

Italy (IT) University of Oxford

United Kingdom (GB) Ruhr-Universität Bochum (RUB)

Germany (DE) Novartis AG

Switzerland (CH) Marqués de Valdecilla University Hospital / Hospital Universitario de Marqués de Valdecilla (HUMV)

Spain (ES) Novartis Ireland Limited

Ireland (IE) University of Paris 4 - Paris-Sorbonne / Université paris IV Paris-Sorbonne

France (FR) Nicolaus Copernicus University (NCU) / Uniwersytet Mikołaja Kopernika w Toruniu (UMK)

Poland (PL)

How to cite

APA:

Baraliakos, X., Gossec, L., Pournara, E., Jeka, S., Blanco, R., D'Angelo, S.,... Coates, L. (2020). Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial. In ARTHRITIS & RHEUMATOLOGY. HOBOKEN: WILEY.

MLA:

Baraliakos, Xenofon, et al. "Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2020.

BibTeX: Download